Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. - Wikidata - wikimedia - TriplyDB

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.

http://www.wikidata.org/entity/Q43885509

about

The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms.Expression of claudin 1, 4 and 7 in thyroid neoplasms.The Immunocytochemistry Is a Valuable Tool in the Diagnosis of Papillary Thyroid Cancer in FNA's Using Liquid-Based Cytology Diagnostic utility of galectin-3 in thyroid cancer.Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia.Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.The Diagnostic Usefulness of HMGA2, Survivin, CEACAM6, and SFN/14-3-3 δ in Follicular Thyroid Carcinoma.Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.Employing genetic markers to improve diagnosis of thyroid tumor fine needle biopsy.Follicular Thyroid Carcinoma Metastatic to the Kidney: Report of a Case with Cytohistologic Correlation.Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma.Galectin-3 Immunohistochemical Expression in Thyroid Neoplasms.A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping Prognostic and predictive factors in endocrine tumours.Pitfalls in thyroid tumour pathology.Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology.Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms.Serum biomarkers of papillary thyroid cancer What is New on Thyroid Cancer Biomarkers Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.Biomarker panel diagnosis of thyroid cancer: a critical review.Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions Absent CD56 expression in papillary thyroid carcinoma: A finding of potential diagnostic value in problematic cases of thyroid pathology.Clinical implications of molecular markers in follicular cell-derived thyroid cancer.Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer.Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma.Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis.Study of the histological profile of papillary thyroid carcinomas associated with Hashimoto's thyroiditis.

P2860

Q24297950-55CD05BE-A7E5-4F34-9DEB-235B2258D696 Q30488923-909D52CC-A839-4B88-A9B2-7CBFB7DDD47A Q33686147-A8C63625-83BF-4A2D-A8A8-A74E5EB36454 Q33739199-C3AC20CF-BFC8-4A33-B1D6-2795E35392C6 Q33816239-28B771B0-217F-4CB3-9E8E-CF5787373372 Q34378203-6B65025A-890B-406C-BC9C-5834004526EA Q34502078-DA70D97B-8287-45E5-BEF6-AAD101CBB73F Q34687495-B0528040-02FE-472E-AB9F-375260E58796 Q35198957-BE4010D8-00E9-4C2B-BB9E-800DEDF0894A Q35644060-218157A5-E3B6-4617-AA2A-698B4E765CFE Q35690041-34F8037E-980F-4AB8-98E1-91EE525B959F Q35731026-B4AD216A-8D51-470C-83CD-6A7E2DC83604 Q36208924-C4F60326-A3F4-4462-A89B-27C903F02FD0 Q36219430-24FCA27C-182F-4175-AC43-861499118229 Q36228107-2DB355EA-C7C3-4C64-B50F-398B30FC487B Q36343453-6B6BD590-B91F-47CC-B1F7-D657B044BEC0 Q36410621-7F392B6D-43D9-45E9-96F9-90D38C69C1EE Q36471713-3C0AC2A9-E6A7-40CD-ACB4-1FF1639C929F Q36552048-366EEABD-869E-40B3-A81A-6CA2D32AA130 Q36576631-42BC5539-7A51-4DC8-AB7F-DA8A932C8FE4 Q36612077-D47057E3-5F0C-4A9E-AAC1-BE8C6E741CEB Q36742319-8A29098C-DC92-4908-9C7F-9CF2BF00B7FC Q36831011-899302D3-1B9D-44C7-82FD-CE80E1A4E2A2 Q36834893-4B13277E-7F2F-44EF-BE36-47A0A36A8FC4 Q37207279-1E1B086A-A955-4F18-9C09-84B8825C4AD3 Q37221063-EC0F781B-A4E3-4CD4-8B7C-A6778E28F6C2 Q37256811-CD63E80A-4D09-4B95-87AA-EB30C68A20F0 Q37256815-2976AC71-F76E-4A6D-83E1-C241EE55386C Q37436309-83EA1063-FD0B-45E4-9294-08228AC29AA7 Q37536948-E48DB0EE-B1D3-4977-A980-00A1F69F2572 Q37611825-EEC0A685-EC99-4DBC-86FC-E46B36F4D80F Q37621631-0FC8DC23-EB8B-4DCB-A0EE-2BC7881C19BF Q37987579-17D64941-5119-47A7-B16D-84DB2E9B5AD5 Q38206192-E1FA2A75-9084-4F7F-BF24-04D3700B4999 Q38367095-860D8C62-D954-4550-AF4C-2AC8ACEE3D62 Q38388372-1751FA71-3910-4BAB-B814-2F39B58D2925 Q38404012-1B6B3A6E-8A6C-459E-95E7-4E866399E412 Q38628967-61D88E91-539D-46E7-AB7B-7415D4B0D59A Q38663177-7A57D89D-EA04-4764-B260-2DA268DC19A6 Q39351408-A1D9D0F1-FFA2-4CF0-A5F4-A1252F584D5D

P2860

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.

http://www.wikidata.org/entity/Q43885509

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@en

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@nl

type

label

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@en

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@nl

prefLabel

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@en

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@nl

P1433

Q43885509-8033CCFB-4001-4163-9CFB-E542375BE5FE

P1476

Q43885509-8AB21DD7-CB28-4A43-934B-6136749C35B4

P2093

Q43885509-9F1B34EB-13C0-40C2-A2C3-A87E7385E0FA

Q43885509-A0B2BAFA-0FA0-48A8-B78E-448671181D8A

Q43885509-A176D3FA-5939-4FD3-810D-91571873DBCF

Q43885509-B2D5BFDE-E1ED-42C1-A4D0-1AAA3283AC44

Q43885509-C8AEC013-1E26-4AA6-894C-5753B72FB9D9

Q43885509-F66DD5DD-00F9-45A1-B3A9-B07923C4DB70

P2860

Q43885509-1A0D02A1-D137-4181-874A-82B41491717E

Q43885509-3DDA1123-BEF9-4378-9AEC-B3B7ACE2DC58

Q43885509-4B4C1073-ED8C-4127-A1BA-55E531EEACC4

P2888

Q43885509-67106F68-BBD7-4494-B8CC-A72CFA9AD0D2

P304

Q43885509-1C5C7DF4-2DDF-4109-A3AE-1E73D6B57F91

P31

Q43885509-C2661F1F-A0E7-4012-AB7A-DD99AA695AB0

P356

Q43885509-0CCC53AB-5D42-48B8-8FA9-8F5150F84178

P433

Q43885509-D6AD3359-D11D-43C4-8633-44797059CBDC

P478

Q43885509-797FB5BB-45A4-4AF2-A711-36E98BCDC4A5

P577

Q43885509-99AB1A3F-FCCA-4E05-BF09-AFBAA4D55446

P5875

Q43885509-733192B4-36C7-450A-BE30-B589F94AF493

P6179

Q43885509-5FB37A1E-4B54-4284-A5AE-BF9D9832FDD8

P698

Q43885509-84DFD14C-6F0D-4696-871F-511B77E70A05

P921

Q43885509-6F040254-53F6-4D51-8972-32EA90CEEFE5

Q43885509-E5D52736-EE6B-46B3-A857-C1D803EC6009

P356

MODPATHOL.3800235

P1433

Modern Pathology

P1476

Galectin-3, fibronectin-1, CIT ...... l diagnosis of thyroid tumors.

@en

P2093

Albert de la Chapelle

http://www.w3.org/2001/XMLSchema#string

Haikady N Nagaraja

http://www.w3.org/2001/XMLSchema#string

Manju L Prasad

http://www.w3.org/2001/XMLSchema#string

Natalia S Pellegata

http://www.w3.org/2001/XMLSchema#string

Richard T Kloos

http://www.w3.org/2001/XMLSchema#string

Ying Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic and biological subgroups of low-stage follicular thyroid cancer

Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays

Immunohistochemical studies on the localization of fibronectin in human thyroid neoplastic tissues.

P2888

modpathol.3800235

P304

48-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3800235

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8437960

http://www.w3.org/2001/XMLSchema#string

P6179

1024879193

http://www.w3.org/2001/XMLSchema#string

P698

15272279

http://www.w3.org/2001/XMLSchema#string

P921

citation analysis

immunohistochemistry